These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3182430)

  • 1. Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.
    Chan MK; Chau PY; Chan WW
    J Antimicrob Chemother; 1988 Sep; 22(3):371-5. PubMed ID: 3182430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral treatment of peritonitis in CAPD patients with ofloxacin.
    Chan MK; Chau PY; Chan WW
    Nephrol Dial Transplant; 1988; 3(2):194-7. PubMed ID: 3140086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Cheng IK; Ng WS
    Am J Kidney Dis; 1990 Feb; 15(2):155-9. PubMed ID: 2405653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
    Gucek A; Bren AF; Lindic J; Hergouth V; Mlinsek D
    Adv Perit Dial; 1994; 10():144-6. PubMed ID: 7999813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
    Cheng IK; Chan CY; Wong WT
    Perit Dial Int; 1991; 11(1):27-30. PubMed ID: 2049419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Passlick J; Wonner R; Keller E; Essers L; Grabensee B
    Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
    Passadakis P; Oreopoulos D
    Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
    Kampf D; Borner K; Hain H; Conrad W
    Perit Dial Int; 1991; 11(4):317-21. PubMed ID: 1751596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
    Cheng IK; Chau PY; Kumana CR; Chan CY; Kou M; Siu LK
    Perit Dial Int; 1993; 13 Suppl 2():S383-5. PubMed ID: 8399617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).
    Ludlam HA; Barton I; White L; McMullin C; King A; Phillips I
    J Antimicrob Chemother; 1990 May; 25(5):843-51. PubMed ID: 2197264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
    Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
    Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral pefloxacin in the treatment of CAPD peritonitis.
    Tan HW; Kon SP; Chua CT; Ngeow NF
    Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephalexin for the oral treatment of CAPD peritonitis.
    Drew PJ; Casewell MW; Desai N; Houang ET; Simpson CN; Marsh FP
    J Antimicrob Chemother; 1984 Feb; 13(2):153-9. PubMed ID: 6368518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Searle M; Raman GV
    Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.
    Chan MK; Chan PC; Cheng IP; Chan CY; Ng WS
    Nephrol Dial Transplant; 1989; 4(9):814-7. PubMed ID: 2516614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of peritonitis in IPD with oral fluoroquinolone.
    Barretti P; Bignardi JH; Soares VA
    Perit Dial Int; 1994; 14(2):192. PubMed ID: 8043683
    [No Abstract]   [Full Text] [Related]  

  • 18. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Chau PY; Chan WW
    Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Cheng IK; Chan CY; Wong WT; Cheng SW; Ritchie CW; Cheung WC; Lo WK
    Perit Dial Int; 1993; 13 Suppl 2():S351-4. PubMed ID: 8399609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
    Lui SF; Cheng AB; Leung CB; Wong KC; Li PK; Lai KN
    Am J Nephrol; 1994; 14(3):182-6. PubMed ID: 7977477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.